Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Major Salivary Gland Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Malignant Peripheral Nerve Sheath Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Sweat Gland Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Malignant Testicular Leydig Cell Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Malignant Sertoli Cell Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Sex Cord-Stromal Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Lipid-Cell Variant Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Micropapillary Variant Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Pituitary Gland Adenoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Prostate Small Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Malignant Syringoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Nasal Cavity Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Nasal Cavity Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Nasopharyngeal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Undifferentiated Carcinoma Of Nasopharynx
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Oral Cavity Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Oropharyngeal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ovarian Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ovarian Germ Cell Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ovarian Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ovarian Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Pancreatic Endocrine Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 1751 to 1775 of 3,272 assets
Previous
Page 71 of 131
Next